Elena Visentin

Elena Visentin currently serves as the Head of Value & Access at Alfasigma Italia, with a professional background that includes roles such as Associate Director of Value & Market Access at Alfasigma and Galapagos. Visentin has extensive experience in health economics, health technology assessment, and market access strategies, having previously worked as the Health Economics & Health Technology Assessment Manager at Otsuka Pharmaceutical Italy and as Value & Access Manager for chronic conditions at AstraZeneca. Early career highlights include positions at IMS Health and the Coordinamento Regionale Unico sul Farmaco in Regione Veneto, where Elena contributed to economic evaluations and regional drug policy. Elena holds degrees in medical pharmacology from Università degli Studi di Milano and a specialist degree in pharmacy from Università degli Studi di Padova, along with ongoing education at Alma Mater Studiorum – Università di Bologna.